Publication | Closed Access
A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial
71
Citations
0
References
2020
Year
MedicinePathologyBronchial NeoplasmImmune Checkpoint InhibitorShp2 Inhibitor Rmc-4630Cancer TreatmentCancer GeneticsOncologyCell BiologyLung CancerCancer ResearchFirst-in-man Phase 1
No additional data available for this publication yet. Check back later!